Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Alvimopan

A peripherally acting mu-opioid receptor antagonist, approved in the United States in 2008 to speed up the recovery of bowel function after surgery to remove part of the intestine. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?It stays almost entirely in the gut: less than 7% reaches the blood and the little that gets to the brain is pumped back out, so it curbs the effect of opioids on the bowel without reducing pain relief.

AlvimopanGo to the active ingredient →
AlvimopanActive ingredientAlvimopanCat. No. P-A102-001CAS 156053-89-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.